Fidelis Capital Partners, LLC
Annual return '25
+37.2%
SPY '25
+17.7%
Alpha
+19.5ptsvs SPY
Invested
$2.4B
Holdings
76
Trades YTD
0
Performance · Fund vs SPY
Cumulative return · quarterly snapshotsCoverage 94%. 4 quarters of 2025 measured against SPY adj-close benchmark.
Top holdings · current snapshot
Source: 13F-HR01
$SRRK
SCHOLAR ROCK HLDG CORP
Held since at least Q1 2024
9.9%
02
$ABVX
ABIVAX SA
Held since at least Q1 2024
6.7%
03
$SNDX
SYNDAX PHARMACEUTICALS INC
Held since at least Q1 2024
5.5%
04
$RVMD
REVOLUTION MEDICINES INC
Held since at least Q1 2024
5.3%
05
$IMVT
IMMUNOVANT INC
Held since at least Q1 2024
3.6%
06
$PRAX
PRAXIS PRECISION MEDICINES I
Held since at least Q1 2024
3.5%
07
$MBX
MBX BIOSCIENCES INC
Held since at least Q1 2024
2.9%
08
$MLYS
MINERALYS THERAPEUTICS INC
Held since at least Q1 2024
2.8%
09
$ELVN
ENLIVEN THERAPEUTICS INC
Held since at least Q1 2024
2.7%
10
$CGON
CG ONCOLOGY INC
Held since at least Q1 2024
2.7%
Recent trades · Last 90 days
No Form 4 / 13D / 13G trade events on file in the recent window. 13F filers report position snapshots quarterly rather than per-trade events, so this section is most useful for managers who also file Form 4 or 13D/G.
Convergence · Pattern Engine ships in v1.1
30-day windowIn development
Convergence participation lands with the Pattern Engine.
Once the Pattern Engine ships, this section will list every active convergence event this fund is named in — with the other named funds, the Congress members on the same name, and combined position size.
Source data: SEC EDGAR · 13F-HR filings · Performance through 2025-12-31 · Last refreshed 06:30 UTC.